Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Osteoarthritis Therapeutics Market to reach USD 14428.44 million by the end of 2029.

Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis) by Drug Type (Viscosupplementation Agents, Non-steroidal Anti-inflammatory Drugs, Analgesics,Corticosteroids), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

Product Code: HLSDT-23704271
Publish Date: 13-05-2023
Page: 200

Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029. One of the most prevalent chronic health disorders, osteoarthritis is characterised by persistent pain, impairment, and decreased mobility. It is a degenerative condition of the joints that worsens with time and is brought on by the deterioration and eventual loss of cartilage in one or more joints. An example of cartilage is present in the joints between bones include the knee, ankle, and elbow. It assists in lubricating the joint and lowering friction. Treatment for osteoarthritis aims to reduce pain and improve functional status. The Osteoarthritis Therapeutics market is expanding because of factors such as Increasing prevalence of osteoarthritis and Growing population susceptible to osteoarthritis.

According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.

The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region’s increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Pfizer, Inc
Eli Lilly and Company
Horizon Therapeutics plc
Ferring B.V.
Merck Sharp & Dohme Corp.
GlaxoSmithKline Plc.
Johnson & Johnson Private Limited
Bayer AG
Novartis AG
Pacira Pharmaceuticals, Inc

Recent Developments in the Market:
Ø In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
Ø In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.

Global Osteoarthritis Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Anatomy, Drug Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Anatomy:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis

By Drug Type:
Viscosupplementation Agents
Non-steroidal Anti-inflammatory Drugs
Analgesics
Corticosteroids
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Osteoarthritis Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Osteoarthritis Therapeutics Market Dynamics
3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis
3.1.1.2. Growing population susceptible to osteoarthritis
3.1.2. Market Challenges
3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
3.1.2.2. Commercialization of alternatives
3.1.3. Market Opportunities
3.1.3.1. Rising number of sports injuries
3.1.3.2. Development of Personalized medicines
Chapter 4. Global Osteoarthritis Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Osteoarthritis Therapeutics Market, by Anatomy
6.1. Market Snapshot
6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance – Potential Analysis
6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
6.4.1. Knee Osteoarthritis
6.4.2. Hip Osteoarthritis
6.4.3. Hand Osteoarthritis
6.4.4. Small Joint Osteoarthritis
Chapter 7. Global Osteoarthritis Therapeutics Market, by Drug Type
7.1. Market Snapshot
7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance – Potential Analysis
7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
7.4.1. Viscosupplementation Agents
7.4.2. Non-steroidal Anti-inflammatory Drugs
7.4.3. Analgesics
7.4.4. Corticosteroids
Chapter 8. Global Osteoarthritis Therapeutics Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
Chapter 9. Global Osteoarthritis Therapeutics Market, Regional Analysis
9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
9.2. North America Osteoarthritis Therapeutics Market
9.2.1. U.S. Osteoarthritis Therapeutics Market
9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Osteoarthritis Therapeutics Market
9.3. Europe Osteoarthritis Therapeutics Market Snapshot
9.3.1. U.K. Osteoarthritis Therapeutics Market
9.3.2. Germany Osteoarthritis Therapeutics Market
9.3.3. France Osteoarthritis Therapeutics Market
9.3.4. Spain Osteoarthritis Therapeutics Market
9.3.5. Italy Osteoarthritis Therapeutics Market
9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
9.4.1. China Osteoarthritis Therapeutics Market
9.4.2. India Osteoarthritis Therapeutics Market
9.4.3. Japan Osteoarthritis Therapeutics Market
9.4.4. Australia Osteoarthritis Therapeutics Market
9.4.5. South Korea Osteoarthritis Therapeutics Market
9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
9.5.1. Brazil Osteoarthritis Therapeutics Market
9.5.2. Mexico Osteoarthritis Therapeutics Market
9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
9.6. Rest of The World Osteoarthritis Therapeutics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer, Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lilly and Company
10.2.3. Horizon Therapeutics plc
10.2.4. Ferring B.V.
10.2.5. Merck Sharp & Dohme Corp.
10.2.6. GlaxoSmithKline Plc.
10.2.7. Johnson & Johnson Private Limited
10.2.8. Bayer AG
10.2.9. Novartis AG
10.2.10. Pacira Pharmaceuticals, Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now